GlassScriptPhysician profile
Nicholas George
NPI 1760917074
$678.55
in general payments reported to CMS, 2019-2025
13 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $196 · 2024: $22.18 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $243.76 | 2023-2025 | Jesduvroq, Benlysta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $139.81 | 2025 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.15 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $33.98 | 2025 | |
| Novo Nordisk INC | $32.41 | 2025 | Wegovy |
| Inspire Medical Systems, INC. | $24.93 | 2025 | Inspire |
| Dexcom, INC. | $23.67 | 2025 | Dexcom G6 Transmitter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.18 | 2024 | Lifevest |
| Dynavax Technologies Corporation | $20.82 | 2025 | Heplisav-B |
| Pfizer INC. | $20.52 | 2025 | |
| Sanofi-Aventis U.S. LLC | $17.64 | 2025 | |
| Lilly USA, LLC | $15.48 | 2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $14.20 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.